Objectives-To prospectively investigate the diagnostic accuracy and clinical consequences of power Doppler morphologic criteria and shear wave elastography (SWE) as complementary imaging methods for evaluation of suspected local breast cancer recurrence in the ipsilateral breast or chest wall.
L ocoregional breast cancer recurrence is defined as any breast cancer or ductal carcinoma in situ in the ipsilateral breast, lymph nodes (axillary, infraclavicular, supraclavicular, internal mammary/parasternal, or intramammary), or chest wall after initial breast cancer treatment. 1 The 10-year rate of locoregional recurrence ranges from 10% to 20% of patients treated by breast-conserving surgery and radiation and 10% to 12% after mastectomy. 2, 3 Substantial clinical and histopathologic factors associated with an increased risk of locoregional recurrence are age younger than 40 years, tumor size greater than 5 cm, metastatic lymph nodes, margin status, an extensive intraductal component, and lymphovascular invasion. [4] [5] [6] [7] [8] [9] [10] [11] There is evidence that early detection of recurrence in asymptomatic patients during posttreatment followup has potential benefits. [12] [13] [14] However, posttreatment surveillance programs for patients with breast cancer have not yet been firmly established. 15 A regular history, physical examination, and mammography are usually recommended for breast cancer follow-up. 16 Ultrasonography (US) is a useful surveillance imaging method for the breast, axillary areas, and chest wall in women who have received breast cancer treatment. 15 Ultrasonography can show ipsilateral recurrent or contralateral metachronous breast cancers with higher sensitivity (91%-97%) than palpation or mammography, which have achieved sensitivity values of 45.5% to 79.0% and 45.0% to 87.0%, respectively. 15 However, a higher cancer detection yield is associated with an increased rate of false-positive findings. 17 Magnetic resonance imaging has high sensitivity and specificity for differentiating posttreatment breast changes from recurrent malignancies, particularly when performed more than 12 months after treatment with either breast-conserving surgery and radiotherapy or mastectomy. 15, 18 However, the diagnostic capabilities of magnetic resonance imaging do not seem to justify the elevated costs associated with its routine use for the detection of breast cancer recurrence. 15, 18, 19 Positron emission tomography/computed tomography has sensitivity of 97% and specificity of 92% for the diagnosis of locoregional breast cancer recurrence. It is also highly sensitive for determining whether the recurrence has disseminated. 20 Thus, information gained from positron emission tomography/computed tomography may change clinical management in almost 50% of patients. 20 On the other hand, evidence of the cost-effectiveness of this modality is lacking. There is also a hazard of radiation exposure and absence of specific clinical indications. 15 Initially introduced in 2003, elastography evaluates tissue stiffness of different structures by US. 21 Analogous to palpation, breast lesions interpreted as hard on elastography are more often malignant. [22] [23] [24] Many studies have demonstrated that elastography can increase the accuracy of conventional B-mode US in the differentiation between benign and malignant lesions. [24] [25] [26] [27] [28] [29] However, to the best of our knowledge, this technology has still not been used in patients with a suspicion of local breast cancer recurrence in the ipsilateral breast or chest wall.
Another tool that can improve the accuracy of US is power Doppler imaging. Several clinical trials have shown that color and power Doppler US can successfully distinguish between benign and malignant breast lesions. [30] [31] [32] However, only a few studies have investigated the role of power Doppler US in suspected breast cancer recurrence. One study showed that power Doppler US had sensitivity of 94.7% and specificity of 98.4%. 33 In another study, its accuracy was shown to be 80%. 34 Qualitative Doppler and elastographic parameters were incorporated into the latest edition of the American College of Radiology Breast Imaging Reporting and Data System (BI-RADS) for US in the description of breast masses. 35 However, the BI-RADS for US is still not informative about the actual use of Doppler US and elastography, particularly as complementary imaging modalities for B-mode US evaluations of suspected local breast cancer recurrence. Therefore, the purpose of this study was to prospectively investigate the diagnostic accuracy and clinical consequences of power Doppler US and shear wave elastography (SWE) as complementary imaging methods for clinical and imaging evaluations of suspected local breast cancer recurrence in the ipsilateral breast or chest wall.
Materials and Methods
The Institutional Review Board approved this study of diagnostic test accuracy. All study participants signed an informed consent form.
Participants
Study participants were consecutively selected for 1 year at the breast imaging section of a referral university center. From July 2016 to June 2017, 29 patients with 32 masses that had a B-mode US suspicion of local breast cancer recurrence in the ipsilateral breast or chest wall were invited to participate in this prospective study.
Indications for breast US were complementary US follow-up of women who had been treated for breast cancer (10 of 32 masses) and masses reported as suspicious for local breast cancer recurrence in the ipsilateral breast or chest wall by clinical examination (9 of 32 masses), mammography (9 of 32 masses), or computed tomography (4 of 32 masses). All masses were managed by US-guided 14-gauge core needle biopsy or surgery. Masses that were unequivocally depicted as benign by mammography (BI-RADS mammographic category 2) were excluded from this study.
Ultrasonographic Examinations
Diagnostic equipment consisted of an Acuson S2000 US machine (Siemens AG, Munich, Germany). The same physician with 15 years of experience in breast imaging performed all B-mode, Doppler, and elastographic examinations with a 9-MHz linear transducer. All measures were obtained in the longest-axis plane of the mass. Only representative high-quality images were selected and stored on the US machine.
All masses were classified as suspicious on B-mode US (BI-RADS category 4 or 5) based on the latest edition of BI-RADS lexicon. 35 During conventional Bmode grayscale imaging, the mass size (maximal diameter) was measured.
Vascular morphologic characteristics of each mass were assessed by power Doppler imaging. We were careful to apply as little pressure as possible on the transducer to avoid affecting the blood flow in small vessels. The pulse repetition frequency was adjusted to low flow (488 Hz). The gain was set to obtain optimal staining of blood vessels without artifacts. The sample box was adjusted to include the breast mass and adjacent breast parenchyma without angulation ( Figure 1 ). 35 Shear wave elastographic images of each breast mass were acquired. B-mode US depicted the masses. The angle of the transducer was kept perpendicular to the skin, applying minimal pressure on the breast. The sample box was adjusted to include the breast mass and adjacent breast parenchyma. The SWE velocity map was obtained, displaying the SWE velocity distribution in 2-dimensional color images. Red, green, and blue indicated hard, intermediate, and soft elasticity, respectively. The SWE velocity map was adjusted from 0.5 (blue) to 6.5 (red) cm/s. Quantitative SWE values were obtained from the static velocity map with Virtual Touch quantification by placing a 2-mm square region of interest on the stiffest part of the mass or on the immediately adjacent tissue if it showed higher stiffness values than the mass itself. The SWE maximum elasticity was recorded.
All power Doppler morphologic features and SWE velocity map images were later retrieved from the US machine and described according to a common consensus between 2 physicians with 8 and 15 years of experience in breast imaging. Both physicians were blinded to histopathologic results.
Morphologic vascular criteria detected by power Doppler US were described as avascular, hypovascular, or hypervascular. The result was classified as negative in avascular and hypovascular masses and positive in hypervascular masses (Figure 1 ). 35 Elasticity images were assigned elasticity scores on a 5-point scale (SWE score), according to the degree and distribution of elasticity on velocity map images. 36, 37 For this 5-point classification, a score of 1 indicated that the entire mass was evenly blue. A score of 2 indicated a mosaic pattern of blue and green. A score of 3 indicated that the mass was half red and half green. A score of 4 indicated that the entire lesion was red or mostly red with a little green. A score of 5 indicated that the entire mass and its surrounding area were red or mostly red with a little green (Figure 2) . 36, 37 Statistical Analyses Continuous variables were described as mean, standard deviation, and range. Categorical variables of the main pathologic diagnosis of the primary tumor and primary breast cancer therapy were described as frequencies and
Diagnostic accuracy was assessed by the sensitivity and specificity, 95% confidence interval (CI), and area under the curve (AUC). The AUCs between the SWE score and SWE maximum elasticity were compared according to the method of DeLong et al. 38 The optimal cutoff values for the SWE score and SWE maximum elasticity for benign/malignant differentiation were obtained by a receiver operating characteristic curve.
The clinical consequences of the power Doppler morphologic criteria, SWE score, and SWE maximum elasticity compared to biopsy of all breast masses or no biopsy were assessed by the plotted net benefit from a decision curve analysis using R statistical software (R Foundation for Statistical Computing, Vienna, Austria). All remaining statistical analyses were calculated with MedCalc version 17.5.5 software (MedCalc Software bvba, Ostend, Belgium). The reference standard was defined as core needle or excisional biopsy. P < .05 was considered significant.
Results
The final pathological diagnoses revealed 23 of 32 (71.8%) malignant and 9 of 32 (28.2%) benign breast masses. Among the malignant lesions, there were 20 invasive ductal carcinomas, 1 ductal carcinoma in situ, 1 invasive lobular carcinoma, and 1 mucinous carcinoma. All benign masses were diagnosed as breast fibrosis (3 scarlike fibrosis, 3 scarlike hyalinizing fibrosis, 2 scarlike fibrosis associated with a granulomatous foreign bodytype reaction, and 1 scarlike fibrosis associated with steatonecrotic foci).
The participants included 28 female patients and 1 male patient. The mean patient age 6 SD was 57.0 6 9.7 years (range, 33-75 years). The interval between chemotherapy and primary surgery, between primary surgery and radiotherapy, or between radiotherapy and chemotherapy ranged from 3 to 6 weeks. The mean interval between primary surgery and B-mode US of suspected local breast cancer recurrence was 52.9 6 58.9 months (range, 2-236 months). The mean size of the 32 breast masses was 13.4 6 6.7 mm (range, 5-35 mm).
Breast-conserving surgery had been performed in most of the patients (24 of 32 [75%]), followed by external radiation to the axilla and breast parenchyma ( Table 1 ).
The AUCs showed that the performance of the SWE maximum elasticity was comparable to the SWE score. The slight difference between curves was not statistically significant (P 5 .32; Figure 3) .
Net benefits regarding the percentage of local breast cancer recurrence and a wide range of exchange rates were plotted for the power Doppler morphologic criteria, SWE score, and SWE maximum elasticity. Two clinical alternatives were also considered: biopsy of all masses and no biopsy. The exchange rate net benefit favored biopsy of all B-mode-suspected masses until a risk threshold of about 50%. This cutoff point was related to a cost-benefit ratio of about 2:3. On the other hand, net benefits of the exchange rate did not significantly favor power Doppler US at any risk threshold (Figure 4) . Receiver operating characteristic curves. Power Doppler US had sensitivity of 34.8% (95% CI, 6.6%-62.9%) and specificity of 45.4% (95% CI, 19.3%-71.5%). The SWE score, taking into account the best trade-off between sensitivity and specificity (score 3), had sensitivity of 87.0% (95% CI, 66.4%-97.2%) and specificity of 44.4% (95% CI, 13.7%-78.8%). The SWE maximum elasticity, taking into account the best trade-off between sensitivity and specificity (velocity > 6.5 cm/s), had sensitivity of 87.0% (95% CI, 66.4%-97.2%) and specificity of 77.8% (95% CI, 40.0%-97.2%). The AUCs for the SWE score and SWE maximum elasticity were 0.71 (95% CI, 0.53-0.87) and 0.82 (95% CI, 0.64-0.93), respectively (P 5.32).
Discussion
Our study confirmed that B-mode US has a good positive predictive value (23 of 32 [71.8%]) for clinical and imaging evaluations of suspected local breast cancer recurrence in the ipsilateral breast or chest wall. It was much higher than the positive predictive value (8.4%-13.7%) of US resulting in biopsy recommendations at screening examinations. 39 Nevertheless, almost onethird of our breast masses (9 of 32 [28.2%]) still underwent an unnecessary biopsy ( Figure 5 ), which can be particularly unpleasant to patients previously treated for breast cancer.
A previous study showed that a combination of Bmode US, elastography, and Doppler US improves radiologist performance in the differentiation between benign and malignant breast lesions compared to Bmode US alone. 39 This finding encouraged us to assess the performance of SWE and power Doppler morphologic criteria to further characterize masses suspected of breast cancer recurrence in the ipsilateral breast or chest wall by B-mode US. Both the SWE score and SWE maximum elasticity distinguished local breast cancer recurrence from fibrosis in our study (P 5 .05 and .002, respectively). The best cutoff points (score 3 and velocity > 6.5 cm/s, respectively) were also consistent with values previously established for differentiating generic benign from malignant lesions. 21, 40 In contrast, in our study, hypervascular masses were not more frequently malignant than their avascular or hypovascular counterparts, according to power Doppler morphologic criteria (P 5 .62). It has been shown that color or power Doppler US has wide ranges of sensitivity (68.0%-91.2%) and specificity (92.7%-95%), depending on diagnostic criteria (morphologic versus quantitative criteria). 32, 39, 41, 42 Many Doppler US criteria have been analyzed to differentiate malignant from benign breast lesions, including the location, shape, and penetration of Doppler vascular signals. 42 In this study, we consistently used the BI-RADS lexicon, which classifies vascularity as avascular, hypovascular, or hypervascular. Only power Doppler US was assessed because it is more sensitive than color Doppler US for detection of vascular signals. 35, 42 Our data suggest that fibrosis may remain hypervascular for many years. On the other hand, about one-third (8 of 23 [34. 8%]) of cancer recurrences were hypovascular or avascular. This finding makes power Doppler US unsuitable for discrimination between local breast recurrence and fibrosis.
A decision curve is a simple type of decision analysis. Benefit and harm outcomes are put on the same scale and plotted against a wide range of exchange rates, in terms of the percentage of cancer risk. 43 The interpretation of a decision curve is that the strategy with the highest net benefit at a particular threshold probability has the highest clinical value. In our study, net benefits only favored the SWE score and SWE maximum elasticity as adjunct variables over biopsies in all study patients, at a cost-benefit ratio of about 2:3 and a risk threshold for cancer of about 50%. It would be a good trade-off to do 5 biopsies to find 2 local breast cancer recurrences. However, a 50% risk threshold is much higher than the 2% recommended for breast biopsy. 35 Evidence that early detection of recurrence is potentially beneficial to asymptomatic patients during posttreatment follow-up makes this risk threshold unreasonable and unsuitable, since no physician or patient would demand a greater than 50% risk of local breast cancer recurrence before an indication for a biopsy. [12] [13] [14] 43 To the best of our knowledge, our study was the first to assess the diagnostic accuracy and clinical consequences of these complementary imaging methods for the evaluation of suspected local breast cancer recurrence. Our study had some limitations. First, our sample size was relatively small and associated with a wide 95% CI for the diagnostic accuracy of power Doppler US, the SWE score, and the SWE maximum elasticity. The sample size may explain why the difference between AUCs for the SWE score and SWE maximum elasticity was not statistically significant. Nevertheless, our sample was suitable to demonstrate a significant relationship between SWE and local breast cancer recurrence in the ipsilateral breast or chest wall. Most importantly, clinical consequences could be assessed. A second limitation was that highly experienced physicians performed all B-mode US examinations. This factor may have reduced the external validity of our findings. Thus, power Doppler US and SWE still require assessment at nonspecialized imaging laboratories, where many patients receive follow-up care after breast cancer treatment.
In conclusion, although the SWE score and SWE maximum elasticity can discriminate between local breast cancer recurrence and fibrosis, the use of these methods to determine biopsy may lead to poorer clinical outcomes than the current practice of performing biopsies of all suspicious masses.
